Complications in premature infants

References

• Hack M, Fanaroff AA, Merkatz IR. The low-birth-weight infant: evolution of a changing outlook. N Engl J Med 1979: 301(21): 1162–5
   PubMed Web of Science ®Google Scholar
• Knobloch H, Malone A, Ellison PH, et al. Considerations in evaluating changes in outcome for infants weighing less than 1.501 grams. Pediatrics 1982: 69(3): 285–95
   PubMed Web of Science ®Google Scholar
• Hirata T, Epcar JT, Walsh A, et al. Survival and outcome of infants 501 to 750 grams: a six-year experience. J Pediatr 1983: 102(5): 741–8
   PubMed Web of Science ®Google Scholar
• Koope BL, Morgan LJ, Battaglia FC. Neonatal mortality risk In relation to birth weight and gestational age: update. J Pediatr 1982: 101(6): 969–77
   PubMed Web of Science ®Google Scholar
• Little GA, Philips AG. A low birth weight survival chart. Perinatol/Neonatol 1983: 7(9): 45–55
   Google Scholar
• Britton SB, Fitzhardinge PM, Ashby S. Is intensive care justified for infants weighing less than 801 gm at birth? J Pediatr 1981;99(6): 937–43
   PubMed Web of Science ®Google Scholar
• Horwood SP, Boyle MH, Torrance GW, et al. Mortality and morbidity of 500- to 1,499-gram birth weight infants live-born to residents of a defined geographic region before and after neonatal intensive care Pediatrics 1982: 69: (5): 613–20
   Google Scholar
• Bennett FC, Robinson NM, Sells CJ. Growth and development of infants weighing less than 800 grams at birth. Pediatrics 1983;71(3): 319–23
   PubMed Web of Science ®Google Scholar
• Neal WA, Reynolds JW, Jarvis CW, et al. Umbilical artery catheterization: demonstration of arterial thrombosis by aortography. Pediatrics 1972: 50(1): 6–13
   PubMed Web of Science ®Google Scholar
• Huch R, Huch A, Albani M, et al. Transcutaneous PO2 monitoring in routine management of infants and children with cardiorespiratory problems. Pediatrics 1976;57(5): 681–90
   PubMed Web of Science ®Google Scholar
• Lucy JF. Transcutaneous diagnosis in the high-risk neonate. Hosp Pract 1981: 16: 109–24
   Web of Science ®Google Scholar
• Merritt TA, Liyamasawad S, Boettrich C, et al. Skin-surface CO2 measurement in sick preterm and term infants. J Pediatr 1981: 99(5): 782–6
   PubMed Web of Science ®Google Scholar
• Kitterman JA, Edmunds LH Jr, Gregory GA, et al. Patent ductus arteriosus in premature infants: incidence, relation to pulmonary disease and management. N Engl J Med 1972: 287(10): 473–77
   PubMed Web of Science ®Google Scholar
• Emmanouilides GC. Incidence, perinatal factors and natural history. Ross Conference on Ductus Arteriosus. Columbus, OH: Ross Laboratories, 1979: 63–8
   Google Scholar
• Siasai B, Blanco C, Cabal LA, et al. Incidence and clinical features of patent ductus arteriosus In lowbirthweight infants: a prospective analysis of 150 consecutively born infants. Pediatrics 1976: 57(3): 347–51
   PubMed Web of Science ®Google Scholar
• Ellison RC, Peckham GJ, Lang P, et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 1983: 71(3): 364–72
   PubMed Web of Science ®Google Scholar
• Brown ER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr 1979: 95(5 Pt 2): 865–6
   PubMed Web of Science ®Google Scholar
• Perlman JM, Hill A, Volpe JJ. The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arteries: ductal steal in the premature newborn infant. J Pediatr 1981: 99(5): 767–71
   PubMed Web of Science ®Google Scholar
• Merritt TA, Disessa TG, Feldman BH, et al. Closure of the patent ductus arteriosus with ligation and indomethacin: a consecutive experience. J Pediatr 1978;93(4): 639–46
   PubMed Web of Science ®Google Scholar
• Mahony L, Carrero V, Brett C, et al. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med 1982: 306(9): 506–10
   PubMed Web of Science ®Google Scholar
• Gersony WM, Peckham GJ, Ellison RC, et al. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983: 102(6): 895–906
   PubMed Web of Science ®Google Scholar
• Leech RW, Kohnen P. Subependymal and intraventricular hemorrhages in the newborn. Am J Pathol 1974: 77(3): 465–75
   PubMed Web of Science ®Google Scholar
• Papile LA, Burstein J, Burstein R, et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978: 92(4): 529–34
   PubMed Web of Science ®Google Scholar
• Volpe JJ. Neonatal intraventricular hemorrhage. N Engl J Med 1981: 304(15): 886–91
   PubMed Web of Science ®Google Scholar
• DeLemos RA, Tomasovic JJ, Null DM Jr. The role of postnatal factors in the pathogenesis of subependymal and intraventricular hemorrhage in the premature infant. Ross Conference on Perinatal Intracranial Hemorrhage. Columbus. OH: Ross Laboratories. 1980: 63–86
   Google Scholar
• Volpe JJ. Neonatal intracranial hemorrhage: pathophysiology, neuropathology, and clinical features. Clin Perinatol 1977;4(1): 77–102
   PubMedGoogle Scholar
• Papile LA, Munsick-Bruno G, Schaefer A. Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. J Pediatr 1983: 103(2): 273–7
   PubMed Web of Science ®Google Scholar
• Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967: 276(7): 357–68
   PubMed Web of Science ®Google Scholar
• Ehrenkranz RA, Bonta BW, Ablow RC, et al. Amelioration of bronchopulmonary dysplasia after vitamin E administration: a preliminary report. N Engl J Med 1978: 229(11): 564–9
   Web of Science ®Google Scholar
• Saldanha RL, Cepeda EE, Poland RL. The effect of vitamin E prophylaxis on the incidence and severity of bronchopulmonary dysplasia. J Pediatr 1982: 101(1): 89–93
   PubMed Web of Science ®Google Scholar
• Shohat M, Reisner SH, Kriskler R, et al. Retinopathy of prematurity: incidence and risk factors. Pediatrics 1983: 72(2): 159–63
   PubMed Web of Science ®Google Scholar
• Hittner HM, Godio LB, Rudolph AJ, et al. Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants. N Engl J Med 1981: 305(23): 1365–71
   PubMed Web of Science ®Google Scholar
• Johnson L. Retrolental fibroplasia: a new look at an unsolved problem. Hosp Pract 1981: 16(5): 109–15, 118–20, 121
   Web of Science ®Google Scholar
• Hittner HM, Godio LB, Speer ME, et al. Retrolental fibroplasia: further clinical evidence and ultrastructural support for efficacy of vitamin E in the preterm infant. Pediatrics 1983: 71(3): 423–32
   PubMed Web of Science ®Google Scholar
• Phelps DL. Vitamin E and retrolental fibroplasia in 1982. Pediatrics 1982;70(3): 420–5
   PubMed Web of Science ®Google Scholar
• Notter RH, Shapiro DL. Lung surfactant in an era of replacement therapy. Pediatrics 1981: 68(6): 781–9
   PubMed Web of Science ®Google Scholar
• Special conference report: high-frequency ventilation for immature infants. Pediatrics 1983: 71: 280–7
   PubMed Web of Science ®Google Scholar
• Majil B. Operating on the fetus: the new frontier in perinatal care. Contemp Ob/Gyn 1983: 216–28
   Google Scholar
• Harrison MR, Filly RA, Golbus MS, et al. Fetal treatment 1982. N Engl J Med 1982;307(26): 1651–2
   PubMed Web of Science ®Google Scholar